Alzheimer’s Drug Maker Faces Criminal Probe Over Reports Of False Research

  • Justice has reportedly launched a criminal investigation into a manufacturer of an Alzheimer’s drug over allegations that the company fabricated research findings for the drug.
  • Federal prosecutors’ investigation into Cassava Sciences centers around whether the company defrauded investors, government agencies, or consumers.
Click to read full article

Sign Up for Our Newsletter

Join our list!

Sign up here to get our daily newsletter with the top trending headlines.